Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Squamous cell carcinoma
ADR ID BADD_A04143
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.16      Miscellaneous and site unspecified neoplasms malignant and unspecified
16.16.01      Neoplasms malignant site unspecified NEC
16.16.01.002      Squamous cell carcinoma
Description A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) [MeSH]
MedDRA Code 10041823
MeSH ID D002294
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Carcinoma epidermoid | Carcinoma squamous | Epidermoid carcinoma | Squamous cell carcinoma | Microinvasive squamous cell carcinoma | Keratin pearl | Keratinizing squamous cell carcinoma | Keratinising squamous cell carcinoma | Planocellular carcinoma | Basaloid squamous cell carcinoma | Squamous cell carcinoma in situ | Carcinoma, Squamous Cell | Carcinomas, Squamous Cell | Squamous Cell Carcinomas | Squamous Cell Carcinoma | Carcinoma, Squamous | Carcinomas, Squamous | Squamous Carcinoma | Squamous Carcinomas | Carcinoma, Epidermoid | Carcinomas, Epidermoid | Epidermoid Carcinoma | Epidermoid Carcinomas | Carcinoma, Planocellular | Carcinomas, Planocellular | Planocellular Carcinoma | Planocellular Carcinomas
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02029Sitagliptin0.000053%
BADD_D02058Sorafenib0.000224%
BADD_D02062Sparfloxacin--
BADD_D02066Spironolactone0.000037%
BADD_D02104Tacrine hydrochloride--
BADD_D02105Tacrolimus0.005644%
BADD_D02106Tadalafil0.000293%
BADD_D02154Tenofovir0.001939%
BADD_D02165Teriflunomide0.000603%
BADD_D02236Tofacitinib0.003303%
BADD_D02331Valsartan0.000053%
BADD_D02342Vedolizumab--
BADD_D02344Vemurafenib0.005384%
BADD_D02345Venetoclax0.000168%
BADD_D02365Vismodegib0.003850%
BADD_D02369Voriconazole0.092936%
BADD_D02370Vorinostat--
BADD_D02375Water--
BADD_D02407Upadacitinib--
BADD_D02412Octreotide--
BADD_D02464Fingolimod0.008801%
BADD_D02487Baricitinib0.000362%
BADD_D02510Rucaparib0.000112%
BADD_D02511Siponimod0.000362%
BADD_D02552Encorafenib0.000112%
The 3th Page    First    Pre   3    Total 3 Pages